David Willoughby, Ph.D., Founder, Manager, and Senior Scientist, received graduate and postdoctoral training in Molecular Biology at The University of Southern California and The Burnham Research Institute, respectively. He has over 15 years of genomics industry experience (Nanogen, CuraGen, ORB), specializing in development of new products for drug discovery and diagnostics.

Libby Handel Ph.D. is Director of Business Development at the Torrey Pines Institute for Molecular Studies, and previously served as Director of Biotechnology Programs at Palm Beach State College. She provides expertise in technology transfer, licensing, and accessing public funding sources.

Dr. Mercer is the Director of Biotechnology at Palm Beach State College and an Adjunct Professor at Nova University. She earned her Ph.D. in Metabolic Sciences from the Department of Molecular Medicine at Columbia University in New York, and completed post-doctoral training in the Department of Cancer Biology at Scripps Florida. Subsequently, she was employed as a Project Manager and Technical Writer in the Scripps-Florida HTS facility for an add